SELLAS Life Sciences Group, Inc. (SLS)
13.21
-2.00
(-13.15%)
USD |
NASDAQ |
Aug 28, 16:00
13.46
+0.25
(+1.89%)
After-Hours: 20:00
SELLAS Life Sciences Group Free Cash Flow : -28.42M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.42M |
| March 31, 2026 | -28.16M |
| December 31, 2025 | -28.39M |
| September 30, 2025 | -30.62M |
| June 30, 2025 | -31.36M |
| March 31, 2025 | -33.71M |
| December 31, 2024 | -35.40M |
| September 30, 2024 | -38.57M |
| June 30, 2024 | -37.66M |
| March 31, 2024 | -35.54M |
| December 31, 2023 | -36.91M |
| September 30, 2023 | -36.24M |
| June 30, 2023 | -35.09M |
| March 31, 2023 | -33.29M |
| December 31, 2022 | -28.31M |
| September 30, 2022 | -23.63M |
| June 30, 2022 | -23.76M |
| March 31, 2022 | -22.90M |
| December 31, 2021 | -26.02M |
| September 30, 2021 | -17.62M |
| June 30, 2021 | -15.37M |
| March 31, 2021 | -13.86M |
| December 31, 2020 | -10.42M |
| September 30, 2020 | -18.02M |
| June 30, 2020 | -18.21M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.48M |
| December 31, 2019 | -17.64M |
| September 30, 2019 | -18.02M |
| June 30, 2019 | -28.37M |
| March 31, 2019 | -30.01M |
| December 31, 2018 | -30.42M |
| September 30, 2018 | -27.61M |
| June 30, 2018 | -15.84M |
| March 31, 2018 | -5.988M |
| December 31, 2017 | -10.99M |
| September 30, 2017 | -17.25M |
| June 30, 2017 | -27.06M |
| March 31, 2017 | -42.10M |
| December 31, 2016 | -44.92M |
| September 30, 2016 | -52.28M |
| June 30, 2016 | -49.04M |
| March 31, 2016 | -49.46M |
| December 31, 2015 | -48.31M |
| September 30, 2015 | -43.81M |
| June 30, 2015 | -49.02M |
| March 31, 2015 | -50.39M |
| December 31, 2014 | -48.40M |
| September 30, 2014 | -51.24M |
| June 30, 2014 | -45.13M |
| March 31, 2014 | -39.42M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Savara, Inc. | -110.66M |
| Lite Strategy, Inc. | -110.42M |
| AbbVie, Inc. | 18.21B |
| Marker Therapeutics, Inc. | -9.756M |
| Rezolute, Inc. | -73.48M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.588M |
| Cash from Financing (Quarterly) | 38.83M |
| Free Cash Flow Per Share (Quarterly) | -0.0401 |
| Free Cash Flow to Equity (Quarterly) | -7.454M |
| Free Cash Flow to Firm (Quarterly) | -7.588M |
| Free Cash Flow Yield | -1.38% |